R. Abdelmalek

461 total citations
51 papers, 319 citations indexed

About

R. Abdelmalek is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, R. Abdelmalek has authored 51 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 10 papers in Pulmonary and Respiratory Medicine and 10 papers in Oncology. Recurrent topics in R. Abdelmalek's work include Parasitic Infections and Diagnostics (8 papers), Infectious Diseases and Tuberculosis (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). R. Abdelmalek is often cited by papers focused on Parasitic Infections and Diagnostics (8 papers), Infectious Diseases and Tuberculosis (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). R. Abdelmalek collaborates with scholars based in Egypt, Tunisia and United Kingdom. R. Abdelmalek's co-authors include Loay Kassem, Kyrillus S. Shohdy, Hamdy A. Azim, Omar Abdel‐Rahman, Sherine M. Rizk, L. Ammari, Karim Aoun, Mahmoud A. Senousy, Laila Ahmed Rashed and A. Bouratbine and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

R. Abdelmalek

48 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Abdelmalek Egypt 11 82 80 67 66 43 51 319
Renata Ferreira Magalhães Brazil 14 71 0.9× 70 0.9× 17 0.3× 145 2.2× 47 1.1× 51 488
Clas Une Costa Rica 10 17 0.2× 78 1.0× 35 0.5× 98 1.5× 48 1.1× 26 497
Daniel V. Vasconcelos-Santos Brazil 18 116 1.4× 32 0.4× 49 0.7× 158 2.4× 70 1.6× 58 969
Simin Kiany Iran 14 34 0.4× 99 1.2× 22 0.3× 95 1.4× 123 2.9× 23 439
Brian T. Campfield United States 11 45 0.5× 25 0.3× 51 0.8× 120 1.8× 94 2.2× 24 367
Marigdalia K. Ramirez‐Fort United States 13 13 0.2× 72 0.9× 110 1.6× 123 1.9× 91 2.1× 47 523
Stef Meers Belgium 9 52 0.6× 61 0.8× 44 0.7× 218 3.3× 33 0.8× 22 416
Mariana Resende Portugal 10 22 0.3× 46 0.6× 19 0.3× 83 1.3× 52 1.2× 15 381
Alexander Philipovskiy United States 10 68 0.8× 88 1.1× 45 0.7× 14 0.2× 138 3.2× 41 430
Maud Brandely France 12 49 0.6× 128 1.6× 68 1.0× 209 3.2× 50 1.2× 19 635

Countries citing papers authored by R. Abdelmalek

Since Specialization
Citations

This map shows the geographic impact of R. Abdelmalek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Abdelmalek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Abdelmalek more than expected).

Fields of papers citing papers by R. Abdelmalek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Abdelmalek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Abdelmalek. The network helps show where R. Abdelmalek may publish in the future.

Co-authorship network of co-authors of R. Abdelmalek

This figure shows the co-authorship network connecting the top 25 collaborators of R. Abdelmalek. A scholar is included among the top collaborators of R. Abdelmalek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Abdelmalek. R. Abdelmalek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Abdelmalek, R., et al.. (2020). The Emerging Treatment Options of Plasmablastic Lymphoma: Analysis of 173 Individual Patient Outcomes. Clinical Lymphoma Myeloma & Leukemia. 21(3). e255–e263. 15 indexed citations
3.
Abdelmalek, R., et al.. (2018). Toxoplasmosis an Overlooked Disease: Seroprevalence in Cancer Patients. PubMed. 19(7). 1987–1991. 21 indexed citations
4.
Abdelmalek, R., et al.. (2018). Validity of a new immunochromatographic test in detection of Toxoplasma gondii in cancer patients. Journal of Parasitic Diseases. 43(1). 83–86. 13 indexed citations
5.
Kassem, Loay, et al.. (2018). Safety issues with the ALK inhibitors in the treatment of NSCLC: A systematic review. Critical Reviews in Oncology/Hematology. 134. 56–64. 37 indexed citations
6.
Abdelmalek, R., et al.. (2018). Transabdominal ultrasonographic features in the diagnosis of gastrointestinal lymphoma. Journal of Gastrointestinal Oncology. 9(6). 1190–1197. 5 indexed citations
7.
8.
Abdelmalek, R., et al.. (2017). Asymptomatic intestinal carriage of microsporidia in HIV-positive patients in Tunisia: prevalence, species, and pathogenesis. Médecine et Santé Tropicales. 27(3). 281–285. 6 indexed citations
9.
Azim, Hamdy A., R. Abdelmalek, & Loay Kassem. (2017). Predicting Brain Metastasis in Breast Cancer Patients: Stage Versus Biology. Clinical Breast Cancer. 18(2). e187–e195. 24 indexed citations
10.
Abdelmalek, R., et al.. (2016). Toxoplasmosis: an overlooked infection in cancer patients. Annals of Oncology. 27. vi479–vi479. 1 indexed citations
11.
Ammari, L., et al.. (2016). Epidemiological and clinical characteristics of neurobrucellosis case patients in Tunisia. Médecine et Maladies Infectieuses. 46(3). 123–130. 9 indexed citations
12.
Azim, Hamdy A., et al.. (2015). Taxane-Based Regimens as Adjuvant Treatment for Breast Cancer: a Retrospective Study in Egyptian Cancer Patients. Asian Pacific Journal of Cancer Prevention. 16(1). 65–69. 4 indexed citations
13.
Abdelmalek, R., et al.. (2015). Efficacy and Toxicity of Sunitinib in Metastatic Renal Cell Carcinoma Patients in Egypt. Asian Pacific Journal of Cancer Prevention. 16(5). 1971–1976. 4 indexed citations
14.
Abdelmalek, R., et al.. (2015). Impact of imatinib interruption and duration of prior hydroxyurea on the treatment outcome in patients with chronic myeloid leukemia: Single institution experience. Journal of the Egyptian National Cancer Institute. 27(2). 69–75. 6 indexed citations
15.
Abdelmalek, R., et al.. (2013). Cutaneous tuberculosis in Tunisia. Médecine et Maladies Infectieuses. 43(9). 374–378. 10 indexed citations
16.
Abdelmalek, R., et al.. (2012). Genotype identification ofEnterocytozoon bieneusiisolates from stool samples of HIV-infected Tunisian patients. Parasite. 19(2). 147–151. 15 indexed citations
17.
Azim, Hatem A., Luigi Santoro, R. Gregory Bociek, Sara Gandini, & R. Abdelmalek. (2009). High dose intensity doxorubicin in aggressive non-Hodgkin's lymphoma: a literature-based meta-analysis. Annals of Oncology. 21(5). 1064–1071. 14 indexed citations
18.
Anane, S., L. Ammari, R. Abdelmalek, et al.. (2009). La mucormycose rhino-orbito-cérébrale chez le diabétique: une pathologie mieux connue en Tunisie. Annales de biologie clinique. 67(3). 325–332. 6 indexed citations
19.
Anane, S., S. Belhadj, R. Abdelmalek, et al.. (2009). Identification d’Enterocytozoon bieneusi par PCR dans les selles des patients immunodéprimés tunisiens. Pathologie Biologie. 59(4). 234–239. 8 indexed citations
20.
Abdelmalek, R., et al.. (2009). Apport de la PCR dans la recherche et l’identification des microsporidies intestinales chez les sujets infectés par le VIH. Pathologie Biologie. 60(2). 91–94. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Renata Ferreira Magalhães Breakdown of academic impact, for papers by Clas Une Breakdown of academic impact, for papers by Daniel V. Vasconcelos-Santos Breakdown of academic impact, for papers by Simin Kiany Breakdown of academic impact, for papers by Brian T. Campfield Breakdown of academic impact, for papers by Marigdalia K. Ramirez‐Fort Breakdown of academic impact, for papers by Stef Meers Breakdown of academic impact, for papers by Mariana Resende Breakdown of academic impact, for papers by Alexander Philipovskiy Breakdown of academic impact, for papers by Maud Brandely
Rankless by CCL
2026